摘要
冠状病毒(cov)是直径60-140纳米、带正电的单链RNA基因组、具有颗粒状特征的包膜病毒,在21世纪初引发了人类致命肺炎的大规模爆发。COVID-19目前被认为是全球持续的潜在大流行威胁。因此,在抑制病毒传播和灭活病毒的创新方法和技术方面已经做出了相当大的努力,但COVID-19疫苗仍处于研发阶段。这一观点侧重于使用无机基纳米材料、金属配合物和金属偶联物的冠状病毒的传感、检测和治疗应用。合成的无机纳米粒子由于其形态上的相似性,与病毒的蛋白质相互作用强烈,因此,许多抗病毒药物已经通过比色法和电化学测定在体外对不同病毒的有效性进行了测试。以金属配合物为基础的药物,如铋配合物形成了一类有吸引力的药物,具有许多治疗应用,包括定量实时荧光定量PCR (Q-RT-PCR)对SARS-CoV解旋酶的抑制和双解活性,磷酸盐释放分析和放射性分析研究。金属偶联物在抑制sars冠状病毒3Clike蛋白酶和RNA依赖RNA聚合酶(RdRp)复制方面发挥主要作用。我们预计,这些方法将为这些创新传感器的开发提供快速和准确的抗病毒策略,用于检测、抑制和抗病毒活性的冠状病毒。
关键词: 冠状病毒(CoV), RNA,金属配合物,金属偶联物,金属纳米颗粒,传感和抑制
Current Medicinal Chemistry
Title:Advances of Inorganic Materials in the Detection and Therapeutic Uses against Coronaviruses
Volume: 28 Issue: 26
关键词: 冠状病毒(CoV), RNA,金属配合物,金属偶联物,金属纳米颗粒,传感和抑制
摘要: Coronaviruses (CoVs) are enveloped viruses with particle-like characteristics and a diameter of 60-140 nm, positively charged, and single-stranded RNA genomes, which caused a major outbreak of human fatal pneumonia in the beginning of the 21st century. COVID-19 is currently considered a continuous potential pandemic threat across the globe. Therefore, considerable efforts have been made to develop innovative methods and technologies for suppressing the spread of viruses as well as inactivating the viruses but COVID-19 vaccines are still in the development phase. This perspective focuses on the sensing, detection and therapeutic applications of CoVs using inorganic- based nanomaterials, metal complexes, and metal-conjugates. Synthetic inorganic- based nanoparticles interact strongly with proteins of viruses due to their morphological similarities, and therefore, numerous antivirals have been tested for efficacy against different viruses in vitro through colorimetric and electrochemical assays. Metal complexes- based agents such as bismuth complexes form an attractive class of drugs with a number of therapeutic applications, including the inhibition and duplex-unwinding activity of SARS-CoV helicase by quantitative real-time PCR (Q-RT-PCR), phosphate release assay and radioassay studies. Metal-conjugates show major effects on inhibiting the 3Clike protease of SARS-CoV and the replication of RNA-dependent RNA polymerase (RdRp). We anticipate that these approaches will provide rapid and accurate antiviral strategies in the development of these innovative sensors for the detection, inhibition and antiviral activities of coronaviruses.
Export Options
About this article
Cite this article as:
Advances of Inorganic Materials in the Detection and Therapeutic Uses against Coronaviruses, Current Medicinal Chemistry 2021; 28 (26) . https://dx.doi.org/10.2174/0929867328666210219142208
DOI https://dx.doi.org/10.2174/0929867328666210219142208 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacotherapy for Obesity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) A Review on Antiproliferative and Apoptotic Activities of Natural Honey
Anti-Cancer Agents in Medicinal Chemistry GIST and Breast Cancer: 3 Case Reports and a Review of the Literature
Current Cancer Therapy Reviews Diagnostic and Therapeutic Applications of Radiolabeled Somatostatin Analogs: Current Status in an Oncology Center
Current Pharmaceutical Design A New Role for Zn(II) Aminopeptidases: Antigenic Peptide Generation and Destruction
Current Pharmaceutical Design Deubiquitinating Enzymes as Promising Drug Targets for Infectious Diseases
Current Pharmaceutical Design Carvacrol Exhibits Chemopreventive Potential against Cervical Cancer Cells via Caspase-Dependent Apoptosis and Abrogation of Cell Cycle Progression
Anti-Cancer Agents in Medicinal Chemistry miRNA and Proteomic Dysregulation in Non-Small Cell Lung Cancer in Response to Cigarette Smoke
MicroRNA New Perspectives in the Pharmacological Treatment of Non-Melanoma Skin Cancer
Current Drug Targets Triggering PIK3CA Mutations in PI3K/Akt/mTOR Axis: Exploration of Newer Inhibitors and Rational Preventive Strategies
Current Pharmaceutical Design Oncolytic Adenovirus: Preclinical and Clinical Studies in Patients with Human Malignant Gliomas
Current Gene Therapy Development and Application of Fourier-Transform Infrared Chemical Imaging of Tumour in Human Tissue
Current Medicinal Chemistry Equinatoxin II Potentiates Temozolomide- and Etoposide-Induced Glioblastoma Cell Death
Current Topics in Medicinal Chemistry Antigen-specific Immunotherapy in Ovarian Cancer and p53 as Tumor Antigen
Current Pharmaceutical Design Small Heat Shock Proteins and the Endoplasmic Reticulum: Potential Attractive Therapeutic Targets?
Current Molecular Medicine Functional Role of miR-34 Family in Human Cancer
Current Drug Targets Branched Disulfide-Based Polyamidoamines Capable of Mediating High Gene Transfection
Current Pharmaceutical Design Targeting the Phosphatidylinositol 3-Kinase/AKT Pathway for the Treatment of Multiple Myeloma
Current Medicinal Chemistry Working Towards the Development of Vaccines for the Treatment and Prevention of Early Breast Cancer
Current Cancer Therapy Reviews The Role of Co-Infections in Mother-to-Child Transmission of HIV
Current HIV Research